Crossref
FDA Approves Novel Treatment for Chronic Hepatitis B
JAMA · 13.11.2026
DOI: 10.1001/jama.2026.20049 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA, online erschienen am 13.11.2026. Verfasst von Sari Richmond.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Richmond, S. (2026). FDA Approves Novel Treatment for Chronic Hepatitis B. JAMA. https://doi.org/10.1001/jama.2026.20049
Vancouver
Richmond S. FDA Approves Novel Treatment for Chronic Hepatitis B. JAMA. 2026. doi:10.1001/jama.2026.20049
BibTeX
@article{Richmond2026,
author = {Richmond, Sari},
title = {FDA Approves Novel Treatment for Chronic Hepatitis B},
journal = {JAMA},
year = {2026},
doi = {10.1001/jama.2026.20049}
}
EUVIMED